Medline Inc.
L10
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.07% | 11.39% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.07% | 11.39% | -- | -- | -- |
| Cost of Revenue | 14.27% | 12.62% | -- | -- | -- |
| Gross Profit | 6.22% | 8.11% | -- | -- | -- |
| SG&A Expenses | 11.88% | 10.96% | -- | -- | -- |
| Depreciation & Amortization | 1.73% | 2.70% | -- | -- | -- |
| Other Operating Expenses | 39.58% | 55.84% | -- | -- | -- |
| Total Operating Expenses | 13.53% | 12.11% | -- | -- | -- |
| Operating Income | -4.26% | 3.48% | -- | -- | -- |
| Income Before Tax | -6.25% | 0.28% | -- | -- | -- |
| Income Tax Expenses | 135.19% | 97.83% | -- | -- | -- |
| Earnings from Continuing Operations | -12.47% | -3.46% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.27% | -3.30% | -- | -- | -- |
| EBIT | -4.26% | 3.48% | -- | -- | -- |
| EBITDA | -1.94% | 3.43% | -- | -- | -- |
| EPS Basic | 1,171.52% | 1,588.48% | -- | -- | -- |
| Normalized Basic EPS | 2,883.64% | 2,085.45% | -- | -- | -- |
| EPS Diluted | 1,171.52% | 1,588.48% | -- | -- | -- |
| Normalized Diluted EPS | 2,877.27% | 2,085.45% | -- | -- | -- |
| Average Basic Shares Outstanding | 109.60% | 104.91% | -- | -- | -- |
| Average Diluted Shares Outstanding | 4.82% | 204.91% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.81% | -0.85% | -- | -- | -- |